AAAAI Letter on Rebate Rule with AAFA, APFED and TMS

April 8, 2019
The AAAAI was joined by the Allergy and Asthma Foundation of America, the American Partnership for Eosinophilic Disorders, and The Mastocytosis Society in a letter expressing concern for both patient access and economic implications of a proposed rule, Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Read the letter here.